Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2011–2023 · research · R01
Pleiotropic functions of FOXC2 in EMT, stem cells and breast cancer progression
Sendurai Ayyavoo Mani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2022 · research · R01
Neuroimmune Mechanisms of Recovery from Comorbid Depression and Chronic Pain
Robert Dantzer · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2025 · research · R01
MicroRNA In Diabetic Nephropathy
Farhad R Danesh · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2021 · research · R01
ERK mediated control of Dicer and Drosha in C. elegans
Swathi Arur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2023 · program · P01
Novel Cord Blood-Derived Cellular Therapies
Catherine M. Bollard · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2025 · program · P01
Cell Therapy Core: GMP/Vector Labs
Indreshpal Kaur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2025 · program · P01
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD
Elizabeth J Shpall · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2025 · program · P01
Multivirus-specific T Cells from Naive CB-derived T Cells
Catherine M. Bollard · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2011–2025 · program · P01
Administrative Core
Elizabeth J Shpall · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2010–2020 · research · R01
Post-translational Modification of Actin
Xuetong Shen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2010–2020 · research · R01
Post-translational Modification of Actin
Xuetong Shen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Administrative Supplement to MD Anderson Cancer Center Prostate Cancer SPORE
Christopher J. Logothetis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2020 · research · R01
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2021 · program · P50
MD Anderson Cancer Center Prostate Cancer SPORE
Christopher J. Logothetis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2021 · program · P50
MD Anderson Cancer Center Prostate Cancer SPORE
Christopher J. Logothetis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2021 · program · P50
MD Anderson Cancer Center Prostate Cancer SPORE
Christopher J. Logothetis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
MD Anderson Cancer Center Prostate Cancer SPORE
Christopher J. Logothetis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2025 · research · R01
Role of Rho Kinase in Diabetic Nephropathy
Farhad R Danesh · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2025 · research · R01
Role of Rho Kinase in Diabetic Nephropathy
Farhad R Danesh · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2025 · research · R01
Role of Rho Kinase in Diabetic Nephropathy
Farhad R Danesh · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2022 · research · R01
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2020 · research · R01
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2025 · research · R01
Role of Rho Kinase in Diabetic Nephropathy
Farhad R Danesh · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2020 · research · R01
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Career Enhancement Program
Timothy Charles Thompson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Administrative Core
Christopher J. Logothetis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Targeting Tumor Microenvironment-Induced Therapy Resistance in Prostate Cancer Bone Metastasis
Sue-Hwa Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Developmental Research Program
Timothy Charles Thompson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Integrating Ipilimumab Immunotherapy with Approved Treatment Strategies in CRPC
James P Allison · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Mitochondria, MicroRNA, and Metabolites in Predicting Aggressive Prostate Cancer
Jian Gu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Biospecimen and Pathology
Patricia Troncoso · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2009–2023 · program · P50
Targeting Androgen Receptor and PARP for Synthetic Lethality in CRPC
Timothy Charles Thompson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
SPORE in Brain Cancer
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
SPORE in Brain Cancer
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
SPORE in Brain Cancer
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
SPORE in Brain Cancer
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
SPORE in Brain Cancer
Juan Fueyo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
Biostatistics and Bioinformatics Core (Core C)
Ying Yuan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
Administrative Core (Core A)
Frederick F Lang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2008–2024 · program · P50
Oncolytic Adenoviruses for Glioma Therapy
Frederick F Lang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
